Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NPCE
#2904
Neuropace, Inc. Common Stock
15.610
0
USD
+1.69%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+1.69%
Monthly Change
+9.16%
6 month change
+47.54%
Year Change
+47.54%
Previous Close
15.350
0
Open
15.610
0
Bid
Ask
Low
15.610
0
High
15.610
0
Volume
32
Markets
US Stock Market
Healthcare
NPCE
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
32.56 M
32.8 M
33.08 M
33.31 M
33.67 M
—
Valuation ratios
Enterprise value
410.44 M
435.86 M
404.29 M
381.5 M
557.01 M
1.78 B
Price to earnings ratio
-12.03
-14.99
-13.59
-13.93
-23.39
-65.9
Price to sales ratio
4.08
4.33
3.86
3.44
5.05
16.7
Price to cash flow ratio
-18.16
-20.62
-21.24
-19.66
-45.91
-107.42
Price to book ratio
40.67
7.14
5.65
4.69
26.55
44.03
Enterprise value to EBITDA ratio
-19.98
-23.82
-21.44
-22.14
-35.87
-103.27
Profitability ratios
Return on assets %
-0.06
-0.06
-0.08
-0.03
-0.03
-0.2
Return on equity %
-0.66
-0.27
-0.45
-0.19
-0.14
-1.05
Return on invested capital %
—
-67.6
-88.98
-34.72
-23.86
-215.16
Gross margin %
75.41
76.99
77.09
77.39
77.4
308.87
Operating margin %
-17.02
-22.85
-29.01
-9.51
-6.65
-68.02
EBITDA margin %
-16.97
-22.42
-28.35
-8.88
-6.45
-66.1
Net margin %
-24.46
-29.25
-36.78
-12.78
-10.26
-89.08
Liquidity ratios
Quick ratio
4.48
5.7
4.51
3.94
4.33
18.49
Current ratio
5.37
6.63
5.47
4.86
5.28
22.24
Inventory turnover
0.41
0.38
0.36
0.36
0.34
1.45
Asset turnover
0.22
0.22
0.22
0.26
0.25
0.94
Solvency ratios
Debt to assets ratio
0.63
0.54
0.55
0.55
0.56
2.2
Debt to equity ratio
7.43
2.46
3.02
3.17
3.09
11.75
Long term debt to total assets ratio
0.63
0.54
0.55
0.55
0.56
2.2
Long term debt to total equity ratio
7.43
2.46
3.02
3.17
3.09
11.75
Per share metrics
Operating cash flow per share
-0.16
-0.24
-0.06
-0.06
0.02
-0.34
EBIT per share
-0.13
-0.16
-0.21
-0.08
-0.05
-0.5
EBITDA per share
-0.13
-0.16
-0.2
-0.07
-0.05
-0.49
Total debt per share
2.04
1.9
1.78
1.77
1.8
7.26
Cash per share
1.81
2.11
1.89
1.81
1.87
7.67
Net current asset value per share
2.79
3.1
2.85
2.88
2.87
11.7
Tangible book value per share
0.28
0.77
0.59
0.56
0.58
2.5
Working capital per share
2.27
2.63
2.33
2.29
2.33
9.58
Book value per share
0.28
0.77
0.59
0.56
0.58
2.5
News
Key Catalysts That Will Likely Drive Prospects for NPCE Stock in 2026
NPCE RNS System Explained: Growth Drivers and Setup for 2026
NeuroPace's Seizure ID and New Indication Could Expand RNS Demand
Neuropace (NPCE) chief medical officer sells $399k in stock
NeuroPace, Inc. (NPCE) Q4 2025 Earnings Call Transcript
NeuroPace, Inc. (NPCE) Reports Q4 Loss, Beats Revenue Estimates
NeuroPace beats estimates as Q4 revenue surges 24%, sending shares up 15%
Neuropace earnings beat by $0.10, revenue topped estimates
LivaNova (LIVN) Tops Q4 Earnings and Revenue Estimates
Sight Sciences, Inc. (SGHT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
NeuroPace, Inc. (NPCE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Pacific Biosciences of California (PACB) Reports Q4 Loss, Beats Revenue Estimates